DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Rossari Biotech Limited — Updates

NSE 3 hrs ago·6 Aug 2026, 2:35 pm

Rossari Biotech

Rossari Biotech has informed investors that it will not be participating in the upcoming investors and analysts meet scheduled for Monday, August 10, 2026. This decision means the company will not be holding a scheduled interaction with the market to discuss its financial performance or future strategy during this specific period.

For retail investors, this development is noteworthy as it removes a scheduled opportunity for the management to provide direct guidance. While a single missed meeting does not inherently indicate a problem, it can sometimes create uncertainty regarding the company's current communication strategy or upcoming business updates.

Investors should monitor the company's official disclosures for any alternative communication channels. Keeping an eye on the broader market sentiment and the company's upcoming quarterly results will be crucial to understanding the full impact of this decision.